Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   34    
Direct Shares   1,043,405    

Indirect Shares

   242,109,977      
Direct Value   $77,034,835    

Indirect Value

   $16,212,584,657      
Total Shares   243,153,382      
Total Value   $16,289,619,492      


Incyte Corp $35,333,665 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,209,731 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,146,330 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $563,030 Incyte Corp $35,333,665 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,209,731 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,146,330 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $563,030
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-06-12 559,963 2024-06-12 28,216,015    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-29 205,752 2024-05-29 39,349,751    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE 2024-06-05 20,838 2024-06-05 10,694,996    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-06-05 29,680 2024-06-05 2,725,689    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-06-17 8,636,006    Premium*  
            Immunocore Holdings Adr IMCR 0 2024-05-28 1,515,318    Premium*  
* Premium Members only  

Records found :    503         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 19 of 21
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2018-05-07 4 B $53.70 $6,966,305 I/I 129,715 45,699,587 2.25 -
SGEN Seagen Inc Director   –       •       •   2018-05-08 4 B $54.02 $6,828,339 I/I 126,399 45,825,986 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-25 4 B $55.35 $2,726,182 I/I 48,125 11,324,937 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2020-02-24 4 B $55.45 $4,093,553 I/I 71,123 10,184,170 2.25 %
SGEN Seagen Inc Director   –       •       •   2018-05-18 4 A $56.77 $420,098 I/I 7,400 45,829,686 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-02-25 4 B $57.22 $11,937,248 I/I 206,126 10,373,248 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2020-02-26 4 B $57.82 $5,799,441 I/I 100,000 10,464,977 2.25 %
GHDX Genomic Health Inc Director   –       •       •   2019-07-01 4 A $58.86 $149,740 I/I 2,544 7,641,672 0 -
INCY Incyte Corp   –       •       •   2024-06-12 4 D $60.00 $327,550,980 I/I (5,459,183) 28,182,605 0 -
INCY Incyte Corp Director   –       •       •   2018-12-31 4 A $63.59 $56,849 I/I 894 810,862 0 -
INCY Incyte Corp Director   –       •       •   2018-06-29 4 A $67.00 $56,883 I/I 849 810,289 0 -
INCY Incyte Corp Director   –       •       •   2021-12-15 4 B $67.90 $25,052,340 I/I 350,332 29,687,509 2.25 %
INCY Incyte Corp Director   –       •       •   2018-09-28 4 A $69.08 $56,991 I/I 825 810,564 0 -
INCY Incyte Corp Director   –       •       •   2021-12-16 4 B $71.96 $12,184,411 I/I 169,315 29,856,824 2.25 %
INCY Incyte Corp Director   –       •       •   2021-12-17 4 B $72.77 $78,322,148 I/I 1,075,872 30,932,696 2.25 %
INCY Incyte Corp Director   –       •       •   2020-03-31 4 A $73.23 $57,412 I/I 784 29,291,915 0 -
INCY Incyte Corp Director   –       •       •   2019-09-30 4 A $74.23 $54,039 I/I 728 29,291,207 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-16 4 B $75.66 $20,894,753 I/I 265,298 7,626,298 2.1 %
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-17 4 B $76.10 $7,836,585 I/I 102,421 7,720,234 2.1 %
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-18 4 B $79.16 $4,059,792 I/I 50,902 7,766,918 2.1 %
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-18 4 B $81.09 $6,673,935 I/I 81,379 7,841,556 2.1 %
INCY Incyte Corp Director   –       •       •   2018-03-29 4 A $83.33 $56,998 I/I 684 790,006 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-11 4 B $84.39 $4,609,090 I/I 53,523 13,048,008 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-17 4 B $84.80 $701,254 I/I 8,164 13,105,422 2.25 %
INCY Incyte Corp Director   –       •      –    2019-06-28 4 A $84.96 $52,675 I/I 620 29,290,843 0 -
  503  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19  20   21      
  Page 19 of 21  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us